Hemagglutinin (HA) is most abundant glycoprotein on the influenza virus surface. Influenza
HA promotes viral entry by engaging the receptor and mediating virus–host membrane …

Influenza hemagglutinin (HA) is the major surface glycoprotein on influenza viruses and
mediates viral attachment and subsequent fusion with host cells. The HA is the major target …

Influenza virus evolves rapidly to constantly escape from natural immunity. Most humoral
immune responses to influenza virus target the hemagglutinin (HA) glycoprotein, which is …

Influenza hemagglutinin (HA) is the primary target of the humoral response during
infection/vaccination. Current influenza vaccines typically fail to elicit/boost broadly …

Here, we describe the discovery of a naturally occurring human antibody (Ab), FluA-20, that
recognizes a new site of vulnerability on the hemagglutinin (HA) head domain and reacts …

Influenza virus hemagglutinin (HA) mediates receptor binding and viral entry during
influenza infection. The development of receptor analogs as viral-entry blockers has not …

A limited arsenal of therapies is currently available to tackle the emergence of a future
influenza pandemic or even to deal effectively with the continual outbreaks of seasonal …

Circulating influenza viruses evade neutralization in their human hosts by acquiring escape
mutations at epitopes of prevalent antibodies. A goal for next-generation influenza vaccines …

Human monoclonal antibodies have been identified which neutralize broad spectra of
influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies …

Hemagglutinin (HA) glycoprotein is an important focus of influenza research due to its role in
antigenic drift and shift, as well as its receptor binding and membrane fusion functions …